Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. - Test2 - elhamkhani - TriplyDB

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

http://www.wikidata.org/entity/Q34487189

about

Targeting the latent reservoir to achieve functional HIV cure RNA Interference in the Age of CRISPR: Will CRISPR Interfere with RNAi?Genome-editing Technologies for Gene and Cell Therapy Resources for the design of CRISPR gene editing experiments CRISPR-Cas9: A Revolutionary Tool for Cancer Modelling Strategies for precision modulation of gene expression by epigenome editing: an overview Translational research-the need of a new bioethics approach Efficient and versatile CRISPR engineering of human neurons in culture to model neurological disorders CRISPR/Cas9: Transcending the Reality of Genome Editing.CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells.Using nanoBRET and CRISPR/Cas9 to monitor proximity to a genome-edited protein in real-time.A genome-wide CRISPR screen identifies a restricted set of HIV host dependency factors.A versatile system for rapid multiplex genome-edited CAR T cell generation What is CRISPR/Cas9?Applications of CRISPR technologies in research and beyond.A CRISPR-Based Toolbox for Studying T Cell Signal Transduction.A vector platform for the rapid and efficient engineering of stable complex transgenes Insertional Mutagenesis by CRISPR/Cas9 Ribonucleoprotein Gene Editing in Cells Targeted for Point Mutation Repair Directed by Short Single-Stranded DNA Oligonucleotides.Maternal Supply of Cas9 to Zygotes Facilitates the Efficient Generation of Site-Specific Mutant Mouse Models.Genome surgery using Cas9 ribonucleoproteins for the treatment of age-related macular degeneration.Targeting Treg signaling for the treatment of autoimmune diseases High-Content Analysis of CRISPR-Cas9 Gene-Edited Human Embryonic Stem Cells.CRISPR-mediated Activation of Latent HIV-1 Expression Delivery of Cas9 Protein into Mouse Zygotes through a Series of Electroporation Dramatically Increases the Efficiency of Model Creation CRISPRs for Optimal Targeting: Delivery of CRISPR Components as DNA, RNA, and Protein into Cultured Cells and Single-Cell Embryos.Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.Purity of transferred CD8(+) T cells is crucial for safety and efficacy of combinatorial tumor immunotherapy in the absence of SHP-1.Chimeric antigen receptor-redirected T cells return to the bench Highly Efficient Genome Editing of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9.GapmeR cellular internalization by macropinocytosis induces sequence-specific gene silencing in human primary T-cells.A Cas9 Ribonucleoprotein Platform for Functional Genetic Studies of HIV-Host Interactions in Primary Human T Cells.An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells.Efficient precise knockin with a double cut HDR donor after CRISPR/Cas9-mediated double-stranded DNA cleavage Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange.Highly efficient homology-driven genome editing in human T cells by combining zinc-finger nuclease mRNA and AAV6 donor delivery.Creating and evaluating accurate CRISPR-Cas9 scalpels for genomic surgery.Is autoimmunity the Achilles' heel of cancer immunotherapy?Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS.Advancing chimeric antigen receptor T cell therapy with CRISPR/Cas9.Salient Features of Endonuclease Platforms for Therapeutic Genome Editing

P2860

Q26745923-EDC0EE0A-F27A-4D01-BD23-56FA102CD541 Q26765460-A0AEC81E-D3E6-4155-99AD-243B3DD43EA0 Q26769662-BA12D49A-C5A8-4589-9625-88542C3A2F52 Q26776435-AA1199D5-A581-458E-B382-D4C3F7AA7EC7 Q26782773-E1EC647D-EA3D-4C37-8563-4C90E72EAEE3 Q26782876-8242FC5C-A3A7-4ED8-8052-4C645727E683 Q28069484-D38C8BA4-8717-4BD6-872C-AD948D1546EE Q28588457-E6A9361E-80E5-4ADF-A132-D2B5F8BB9643 Q33632925-D91284BF-510E-4406-8DBA-313638C0515F Q33671867-1C982280-8C06-4DA4-B4C6-1FB23B44566D Q33784472-E47018D7-AB7A-4EED-B993-0A7C6B829318 Q33906477-611E6C56-2BBA-484C-8779-C87271E583BE Q34047977-3147E9A0-6574-4A4D-8C5B-7EB147F873E9 Q34521342-D09096D3-099B-4589-86E9-5A754F7090DA Q34539796-6CB86FDC-BC9D-490B-B107-FA0F91CD7D76 Q35983356-30ADFE55-B7D3-440C-86BF-2BE69265B392 Q36150837-69030065-2961-44DB-A761-BC5E8A74DCA9 Q36239465-A271A186-C979-41D5-945B-51757AA450A2 Q36247871-9FA046A9-3782-4BBA-A7F1-E28A2921DB2A Q36283611-0E56DBF8-A2F0-4C11-A176-E65F052E3A49 Q36372616-813B6C06-AD08-4967-A725-3125B9341328 Q36482298-2D13DA10-60DF-4F70-A716-0D8F668A3D83 Q36675297-31817AE5-3D4A-49EE-A41F-D18F71FE06FE Q36968247-8DC6CA86-7C12-4CFC-95D6-1B9074F30FA9 Q37061159-EFE98348-365C-42BF-8EB6-2B2309FB0067 Q37243530-3471AD1E-8323-4192-84B1-50ACAADF5AE0 Q37263972-01CBF2B2-0822-415D-84BD-621F6965AFF4 Q37301510-A68701D0-609E-4DBD-8B9D-68330CB6E1DD Q37381914-280E7CA0-8EE7-44E1-B0D5-3C8734B449D4 Q37435171-B0E09C01-07FD-4CE2-98B8-AA9B4A5B0E0E Q37441674-9A9469E7-4FDE-4910-8464-7532F2F3895E Q37597919-9A60EEBC-CB97-490A-9F9D-EA864A6C26E9 Q37655265-F2C664A5-0325-4701-9941-B6E6DCDD9ADD Q37736679-8EFD458F-FBF9-49F6-9315-47B373F73BD9 Q38530599-18E3AA53-5205-49E9-A0D9-E8D6BB654338 Q38682882-42F7200A-A32D-49D3-AD16-C2038878D439 Q38687375-BD59B297-BE02-4DB4-8028-FD05F4ABA456 Q38687781-C75BD1C1-D5FE-49E5-9F19-0E5A4769C441 Q38691942-66E596EE-3844-4CAC-8C70-E821F20BBE1E Q38706622-110AF7B3-6AF2-47D8-8C6B-D6A6FF04255A

P2860

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

http://www.wikidata.org/entity/Q34487189

description

2015 nî lūn-bûn

@nan

2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@ast

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@en

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@nl

type

label

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@ast

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@en

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@nl

prefLabel

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@ast

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@en

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins.

@nl

P1433

Q34487189-5AB67B5E-CDA4-44A0-A6FC-FF58720A1CB3

P1476

Q34487189-98138023-F56B-4957-B42E-F2E9C70C6CA6

P2093

Q34487189-10A1E497-F99F-4EAC-A874-C0C84B431338

Q34487189-62845C81-F9D8-4154-AE00-91B067A0FCE6

Q34487189-7686CC46-8538-4591-BB13-931FD39BB7B0

Q34487189-9523D1A6-4AB4-4785-82B9-959523C12740

Q34487189-A52E646C-8FE9-4B19-9C6F-0C551B696EFD

Q34487189-B78314F4-75F9-497C-9481-0DB191651056

Q34487189-C9F73D1F-08CD-47CF-AA2B-3DF75B77CE25

Q34487189-F88FF7E3-EF64-4878-91D7-E7413793072B

P2860

Q34487189-036330B6-B317-486F-BA15-5682B8932271

Q34487189-10C2CC21-3DF1-427F-8FA9-A33F7AF4A82F

Q34487189-173E9799-36CF-453F-94B4-4AB3AC835689

Q34487189-1845311D-58D9-4828-9E3C-D0AA6CC0225C

Q34487189-1995CC62-7478-4CF5-A596-1CB22BEA621B

Q34487189-1A436417-AE2F-4E0B-987F-7654AFE14593

Q34487189-30515AB5-4CC2-4F32-B83F-BD9ECFCC1B9A

Q34487189-35919F79-58FA-488D-A207-B6FCCAADFF5B

Q34487189-38101CAF-BA5E-4A72-A48E-0267913B3862

Q34487189-3F15C404-A9EC-4102-8E9A-7CEAD65B508A

P304

Q34487189-A399693D-9B7E-4F3A-B7FE-0BB0A95D3B0E

P31

Q34487189-DB9E76AA-F9FC-4582-907C-596EB5CAAFF9

P356

Q34487189-F6CC3420-B49D-4155-B685-3729E6CE5640

P407

Q34487189-C5052B4B-81F5-44EE-AC7B-520BAABF18D2

P433

Q34487189-180D5631-9C67-4829-87BD-549CB802AD92

P478

Q34487189-FCDAEBF1-CD5A-470A-B35E-704DFB803A00

P50

Q34487189-06CCDCC1-3990-46C1-B538-DD53B32D84A3

Q34487189-5117B4D9-737C-41F8-90B6-512F68D6BCB2

Q34487189-6F1138E4-EEF3-4FE4-BDAD-0CAF945A660E

P577

Q34487189-D80CDAD1-21DE-4143-B67D-91CD38BF69CA

P5875

Q34487189-40B280DC-4F83-47CA-8FA0-A108D22802D6

P698

Q34487189-5E6567E8-CF80-41EE-AA6F-DBB1B26E23A9

P921

Q34487189-086E8BCA-0CE7-4014-8414-30F380F20227

P932

Q34487189-5AFE5D71-1124-4C07-BEF3-6C814BA774DF

P356

PNAS.1512503112

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Generation of knock-in primary human T cells using Cas9 ribonucleoproteins

@en

P2093

Alexander Marson

http://www.w3.org/2001/XMLSchema#string

Chun J Ye

http://www.w3.org/2001/XMLSchema#string

Dimitre R Simeonov

http://www.w3.org/2001/XMLSchema#string

Eric Boyer

http://www.w3.org/2001/XMLSchema#string

Genevieve E Haliburton

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Bluestone

http://www.w3.org/2001/XMLSchema#string

Meena Subramaniam

http://www.w3.org/2001/XMLSchema#string

Rachel E Gate

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Immune checkpoint blockade: a common denominator approach to cancer therapy

Gene editing of CCR5 in autologous CD4 T cells of persons infected with HIV

Development and applications of CRISPR-Cas9 for genome engineering.

Genome editing. The new frontier of genome engineering with CRISPR-Cas9

Adoptive immunotherapy for cancer: harnessing the T cell response

Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development

Genetic and epigenetic fine mapping of causal autoimmune disease variants

Double-strand break end resection and repair pathway choice

P304

10437-10442

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1512503112

http://www.w3.org/2001/XMLSchema#string

P407

P433

33

http://www.w3.org/2001/XMLSchema#string

P478

112

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Doudna

Kathrin Schumann

P577

2015-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

280493703

http://www.w3.org/2001/XMLSchema#string

P698

26216948

http://www.w3.org/2001/XMLSchema#string

P921

ribonucleoprotein

P932

4547290

http://www.w3.org/2001/XMLSchema#string